Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue BMC Infectious Diseases Année : 2010

Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study

(1) , (1) , (2) , (3) , (4, 5) , (6) , ,
1
2
3
4
5
6

Résumé

Meropenem is a carbapenem that has an excellent activity against many gram-positive and gram-negative aerobic, facultative, and anaerobic bacteria. The major objective of the present study was to assess the in vitro activity of meropenem compared to imipenem and piperacillin/tazobactam, against 1071 non-repetitive isolates collected from patients with bacteremia (55%), pneumonia (29%), peritonitis (12%) and wound infections (3%), in 15 French hospitals in 2006. The secondary aim of the study was to compare the results of routinely testings and those obtained by a referent laboratory.

Dates et versions

hal-03134629 , version 1 (08-02-2021)

Identifiants

Citer

Marie-Laure Joly-Guillou, Marie Kempf, Jean-Didier Cavallo, Monique Chomarat, Luc Dubreuil, et al.. Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study. BMC Infectious Diseases, 2010, 10 (1), Non spécifié. ⟨10.1186/1471-2334-10-72⟩. ⟨hal-03134629⟩
19 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More